Reference is made to the announcement from CSAM Health Group AS (“CSAM”) on 18 December 2020 regarding the agreed acquisition of all shares in Fertsoft AB (“Fertsoft”). Today, CSAM successfully completed the acquisition of all shares in Fertsoft.
The purchase price for the shares will be settled through an issue of 62,247 new CSAM shares to the shareholders of Fertsoft, in accordance with the Fertsoft Share Purchase Agreement.
For more information, contact:
Chief Financial Officer
+47 91 55 45 32
CSAM has established itself as a leading Nordic niche player in the specialised eHealth market with a unique blend of best-in-class innovative technology, and outstanding human skills. The company’s diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. CSAM’s commercial headquarters are located in Oslo, Norway. The company also has local offices in Stockholm, Karlstad, Gothenburg, Uppsala, Copenhagen, Helsinki, Oulu, Tampere, Tromsø and Warwickshire, as well as a wholly owned software engineering subsidiary in the Philippines.
For more information, visit www.csamhealth.com.